Understanding the Role of Chemokines and Cytokines in Experimental Models of Herpes Simplex Keratitis

Tayaba N Azher, Xiao-Tang Yin, Patrick M Stuart, Tayaba N Azher, Xiao-Tang Yin, Patrick M Stuart

Abstract

Herpes simplex keratitis is a disease of the cornea caused by HSV-1. It is a leading cause of corneal blindness in the world. Underlying molecular mechanism is still unknown, but experimental models have helped give a better understanding of the underlying molecular pathology. Cytokines and chemokines are small proteins released by cells that play an important proinflammatory or anti-inflammatory role in modulating the disease process. Cytokines such as IL-17, IL-6, IL-1α, and IFN-γ and chemokines such as MIP-2, MCP-1, MIP-1α, and MIP-1β have proinflammatory role in the destruction caused by HSV including neutrophil infiltration and corneal inflammation, and other chemokines and cytokines such as IL-10 and CCL3 can have a protective role. Most of the damage results from neutrophil infiltration and neovascularization. While many more studies are needed to better understand the role of these molecules in both experimental models and human corneas, current studies indicate that these molecules hold potential to be targets of future therapy.

References

    1. Darougar S., Wishart M. S., Viswalingam N. D. Epidemiological and clinical features of primary herpes simplex virus ocular infection. British Journal of Opthalmology. 1985;69(1):2–6.
    1. Liesegang T. J., Melton L. J., Daly P. J. Ilstrup D. M. Epidemiology of ocular herpes simplex: incidence in Rochester, Minn, 1950 through 1982. Archives of Ophthalmology. 1989;107(8):1155–1159. doi: 10.1001/archopht.1989.01070020221029.
    1. Tang Q., Chen W., Hendricks R. L. Proinflammatory functions of IL-2 in herpes simplex virus corneal infection. The Journal of Immunology. 1997;158(3):1275–1283.
    1. Tsatsos M., MacGregor C., Athanasiadis I., Moschos M. M., Hossain P., Anderson D. Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents. Clinical and Experimental Ophthalmology. 2016;44(9):824–837. doi: 10.1111/ceo.12835.
    1. Gaddipati S., Estrada K., Rao P., Jerome A. D., Suvas S. IL-2/anti-IL-2 antibody complex treatment inhibits the development but not the progression of herpetic Stromal Keratitis. The Journal of Immunology. 2015;194(1):273–282. doi: 10.4049/jimmunol.1401285.
    1. Keadle T. L., Alexander D. E., Leib D. A., Stuart P. M. Interferon gamma is not required for recurrent herpetic stromal keratitis. Virology. 2008;380(1):46–51. doi: 10.1016/j.virol.2008.07.018.
    1. Reichard A. C., Cheemarla N. R., Bigley N. J. SOCS1/3 expression levels in HSV-1-infected, cytokine-polarized and -unpolarized macrophages. Journal of Interferon & Cytokine Research. 2015;35(1):32–41. doi: 10.1089/jir.2013.0070.
    1. Zhang J., An J. Cytokines, inflammation, and pain. International Anesthesiology Clinics. 2007;45(2):27–37. doi: 10.1097/AIA.0b013e318034194e.
    1. Allen S. J., Crown S. E., Handel T. M. Chemokine: receptor structure, interactions, and antagonism. Annual Review of Immunology. 2007;25(1):787–820. doi: 10.1146/annurev.immunol.24.021605.090529.
    1. Su Y.-H., Yan X.-T., Oakes J. E., Lausch R. L. Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection. Journal of Virology. 1996;70(2):1277–1281.
    1. Staats H. F., Lausch R. N. Cytokine expression in vivo during murine herpetic stromal keratitis. Effect of protective antibody therapy. Journal of Immunology. 1993;151(1):277–283.
    1. Tumpey T. M., Cheng H., Cook D. N., Smithies O., Oakes J. E., Lausch R. N. Absence of macrophage inflammatory protein-1α prevents the development of blinding herpes stromal keratitis. Journal of Virology. 1998;72(5):3705–3710.
    1. Suryawanshi A., Veiga-Parga T., Rajasagi N. K., et al. Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal Immunopathology. The Journal of Immunology. 2011;187(4):1919–1930. doi: 10.4049/jimmunol.1100736.
    1. Banerjee K., Biswas P. S., Kim B., Lee S., Rouse B. T. CXCR2−/− mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. The Journal of Immunology. 2004;172(2):1237–1245. doi: 10.4049/jimmunol.172.2.1237.
    1. Suryawanshi A., Veiga-Parga T., Reddy P. B., Rajasagi N. K., Rouse B. T. IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection. Journal of Immunology. 2012;188(7):3434–3446. doi: 10.4049/jimmunol.1102602.
    1. Molesworth-Kenyon S. J., Yin R., Oakes J. E., Lausch R. N. IL-17 receptor signaling influences virus-induced corneal inflammation. Journal of Leukocyte Biology. 2008;83(2):401–408. doi: 10.1189/jlb.0807571.
    1. Fenton R. R., Molesworth-Kenyon S., Oakes J. E., Lausch R. N. Linkage of IL-6 with neutrophil chemoattractant expression in virus-induced ocular inflammation. Investigative Ophthalmology & Visual Science. 2002;43(3):737–743.
    1. Biswas P. S., Banerjee K., Kinchington P. R., Rouse B. T. Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Experimental Eye Research. 2006;82(1):46–54. doi: 10.1016/j.exer.2005.05.001.
    1. Yan X. T., Tumpey T. M., Kunkel S. L., Oakes J. E., Lausch R. N. Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea. Investigative Ophthalmology & Visual Science. 1998;39(10):1854–1862.
    1. Yan X. T., Zhuang M., Oakes J. E., Lausch R. N. Autocrine action of IL-10 suppresses proinflammatory mediators and inflammation in the HSV-1-infected cornea. Journal of Leukocyte Biology. 2001;69(1):149–157.
    1. Kim B., Sarangi P. P., Lee Y., Deshpande Kaistha S., Lee S., Rouse B. T. Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation. Journal of Leukocyte Biology. 2006;80(6):1405–1415. doi: 10.1189/jlb.0406295.
    1. Tang Q., Hendricks R. L. Interferon gamma regulates platelet endothelial cell adhesion molecule 1 expression and neutrophil infiltration into herpes simplex virus-infected mouse corneas. The Journal of Experimental Medicine. 1996;184(4):1435–1447. doi: 10.1084/jem.184.4.1435.
    1. Hendricks R. L., Tumpey T. M., Finnegan A. IFN-y and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. Journal of Immunology. 1992;149(9):3023–3028.
    1. Veiga-Parga T., Giménez F., Mulik S., Chiang E. Y., Grogan J. L., Rouse B. T. Controlling herpetic stromal keratitis by modulating lymphotoxin-alpha-mediated inflammatory pathways. Microbes and Infection. 2013;15(10-11):677–687. doi: 10.1016/j.micinf.2013.07.001.
    1. Tumpey T. M., Elner V. M., Chen S. H., Oakes J. E., Lausch R. N. Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1. Journal of Immunology. 1994;153(5):2258–2265.
    1. Tumpey T. M., Cheng H., Yan X. T., Oakes J. E., Lausch R. N. Chemokine synthesis in the HSV-1-infected cornea and its suppression by interleukin-10. Journal of Leukocyte Biology. 1998;63(4):486–492.
    1. Stuart P. M., Morris J. E., Sidhu M., Keadle T. L. CCL3 protects mice from corneal pathology during recurrent HSV-1 infection. Frontiers in Bioscience. 2008;13:4407–4415.
    1. Gallar J., Tervo T. M., Neira W., et al. Selective changes in human corneal sensation associated with herpes simplex virus keratitis. Investigative Ophthalmology & Visual Science. 2010;51(9):4516–4522. doi: 10.1167/iovs.10-5225.
    1. Hamrah P., Cruzat A., Dastjerdi M. H., et al. Corneal sensation and subbasal nerve alterations in patients with herpes simplex keratitis: an in vivo confocal microscopy study. Ophthalmology. 2010;117(10):1930–1936. doi: 10.1016/j.ophtha.2010.07.010.
    1. Mulik S., Xu J., Reddy P. B., et al. Role of MiR-132 in angiogenesis after ocular infection with herpes simplex virus. The American Journal of Pathology. 2012;181(2):525–534. doi: 10.1016/j.ajpath.2012.04.014.
    1. Suryawanshi A., Mulik S., Sharma S., Reddy P. B., Sehrawat S., Rouse B. T. Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor. Journal of Immunology. 2011;186(6):3653–3665. doi: 10.4049/jimmunol.1003239.
    1. Wuest T. R., Carr D. J. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. The Journal of Experimental Medicine. 2010;207(1):101–115. doi: 10.1084/jem.20091385.
    1. Biswas P. S., Banerjee K., Kim B., Rouse B. T. Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis. Journal of Immunology. 2004;172(6):3736–3744. doi: 10.4049/jimmunol.172.6.3736.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe